Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $8.9700 (-8.38%) ($8.5600 - $9.9300) on Thu. May. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 11.23% (three month average) | RSI | 36 | Latest Price | $8.9700(-8.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -4.8% a day on average for past five trading days. | Weekly Trend | CEMI declines -7.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) BND(83%) PCY(44%) IBB(43%) LQD(41%) VCIT(41%) | Factors Impacting CEMI price | CEMI will decline at least -5.615% in a week (0% probabilities). TBT(-29%) URA(-27%) VXX(-24%) XME(-22%) PAVE(-17%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.615% (StdDev 11.23%) | Hourly BBV | 0 () | Intraday Trend | -8.7% | | | |
|
1 - 5 Day Possible Target | $-8.14(-190.75%) | Resistance Level | $11.54 | 5 Day Moving Average | $10.02(-10.48%) | 10 Day Moving Average | $10.88(-17.56%) | 20 Day Moving Average | $11.54(-22.27%) | To recent high | -42.3% | To recent low | 75.2% | Market Cap | $181m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |